Clinical Trials
Closed
Phase
Accrual
81%
Published
SWOG Clinical Trial Number
S0219
A Sequential Approach to the Treatment of Muscle Invasive, Non-Metastatic Carcinoma of the Bladder: A Phase II Trial of Neoadjuvant Gemcitabine, Paclitaxel and Carboplatin with Molecular Correlates
Research Committee(s)
Genitourinary Cancer
Activated
01-01-2003
Closed
12-15-2006
Closed
Phase
Accrual
10%
SWOG Clinical Trial Number
S0122
Phase II Trial of Patients with Limited Stage Small Cell Lung Cancer Treated with Thoracic Radiation Therapy and Chemotherapy with Cisplatin/Etoposide Followed by Cisplatin/Etoposide and Anti-Idiotype Monoclonal Antibody Vaccines
Research Committee(s)
Lung Cancer
Activated
12-15-2002
Closed
05-15-2003
Closed
Phase
Accrual
9%
SWOG Clinical Trial Number
S0121
Phase II Evaluation of Carboplatin, Paclitaxel and Gemcitabine Followed by Concurrent Cisplatin and Radiation Therapy in Patients with Locally Advanced or Recurrent Urothelial Malignancy
Research Committee(s)
Genitourinary Cancer
Activated
11-15-2002
Closed
06-01-2005
Closed
Phase
Accrual
99%
Published
SWOG Clinical Trial Number
S0124
Randomized Phase III Trial of Cisplatin and Irinotecan versus Cisplatin and Etoposide in Patients with Extensive Stage Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
11-01-2002
Closed
03-01-2007
Closed
Phase
Accrual
47%
SWOG Clinical Trial Number
S0114
An Early Phase Study of an EGFRvIII Peptide Based Vaccine in Patients With EGFRvIII Expressing Cancers
Research Committee(s)
Immunomolecular Therapeutics
Activated
11-01-2002
Closed
06-01-2006
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0213
Pilot Trial of Hyper-CVAD and Methotrexate/ARA C+ Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
Research Committee(s)
Lymphoma
Activated
10-01-2002
Closed
09-01-2006
Closed
Phase
Accrual
2%
SWOG Clinical Trial Number
S0116
A Phase II Trial of a D1/3-MAGE-3-His Fusion Protein (NSC-719274) with Adjuvant SB-AS02B (NSC-719275) for Patients with Selected Stage IV, M1a or M1b Metastatic Melanoma
Research Committee(s)
Melanoma
Activated
09-15-2002
Closed
02-15-2004
Closed
Phase
Accrual
84%
Published
SWOG Clinical Trial Number
S0215
Docetaxel and Vinorelbine Plus Filgrastim with Weekly Trastuzumab for HER-2 Positive, Stage IV Breast Cancer, Phase II Pilot
Research Committee(s)
Breast Cancer
Activated
09-15-2002
Closed
01-01-2007
Closed
Phase
Accrual
6%
Published
SWOG Clinical Trial Number
S0200
A Phase III Randomized Study of Pegylated Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients with Recurrent Epithelial Ovarian or Peritoneal Carcinoma after Failure of Initial Platinum-Based Chemotherapy
Research Committee(s)
Gynecologic Cancer
Activated
08-15-2002
Closed
12-15-2004
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0204
A Phase II Trial of Thalidomide/Dexamethasone Induction Followed by Tandem Melphalan Transplant and Prednisone/Thalidomide Maintenance in Newly Diagnosed Multiple Myeloma Patients, (A BMT Study)
Research Committee(s)
Myeloma
Activated
06-15-2002
Closed
10-15-2005
Closed
Phase
Accrual
97%
Published
SWOG Clinical Trial Number
S0120
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasma Proliferative Disorders
Research Committee(s)
Myeloma
Activated
06-01-2002
Closed
04-01-2011
Closed
Phase
Accrual
88%
Published
SWOG Clinical Trial Number
S0127
A Phase II Study of OSI-774 (NSC #718781) in Unresectable or Metastatic Adenocarcinoma of the Stomach and Gastroesophageal Junction
Research Committee(s)
Gastrointestinal Cancer
Activated
06-01-2002
Closed
08-15-2003
Closed
Phase
Accrual
72%
Published
SWOG Clinical Trial Number
S0000A
PREADVISE, Prevention of Alzheimer's Disease with Vitamin E and Selenium, Phase III Ancillary to S0000 - SELECT
Activated
05-17-2002
Closed
09-30-2009
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0218
A Phase II Study of Oral EGFR Tyrosine Kinase Inhibitor OSI-774 (NSC-718781) In Patients with Malignant Pleural Mesothelioma
Research Committee(s)
Sarcoma
Lung Cancer
Activated
05-01-2002
Closed
04-01-2003
Closed
Phase
Accrual
77%
Published
SWOG Clinical Trial Number
S0211
A Phase II Trial of STI571 for the Treatment of Platinum and Taxane Refractory Stage III and IV Epithelial Ovarian Cancer and Primary Peritoneal Cancer
Research Committee(s)
Gynecologic Cancer
Activated
04-15-2002
Closed
01-01-2006
Closed
Phase
Accrual
50%
Published
SWOG Clinical Trial Number
S0207
Phase II Study of Arsenic Trioxide in Male Patients with Refractory Germ Cell Malignancies
Research Committee(s)
Genitourinary Cancer
Activated
04-01-2002
Closed
03-01-2005
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0119
Phase II Trial of Gemcitabine and Irinotecan in Patients with Untreated Extensive Stage Small Cell Lung Cancer (SCLC)
Research Committee(s)
Lung Cancer
Activated
01-01-2002
Closed
02-15-2003
Closed
Phase
Accrual
2%
SWOG Clinical Trial Number
S0002
Smoking Cessation Intervention (Including Bupropion-Zyban Versus Placebo) for Completely Resected Stage I and Stage II Non-Small Cell Lung Cancer Survivors Who Are Currently Smokers, Phase III
Research Committee(s)
Lung Cancer
Activated
01-01-2002
Closed
01-01-2004
Closed
Phase
Accrual
48%
Published
SWOG Clinical Trial Number
S0032
Phase II Evaluation of Early Oral Estramustine, Oral Etoposide and Intravenous Paclitaxel in Combination with Hormone Therapy in Patients with High-Risk Metastatic Adenocarcinoma of the Prostate
Research Committee(s)
Genitourinary Cancer
Activated
12-01-2001
Closed
06-01-2005
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0126
Phase II Trial of Chronic Oral ZD1839 (Iressa) in Both Previously-Untreated and Previously-Treated Patients with Selected Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC)
Research Committee(s)
Lung Cancer
Activated
12-01-2001
Closed
07-01-2003